Complications Related to Therapeutic Anticoagulation in Total Hip Arthroplasty

Journal of Arthroplasty

Volumn 28, Issue 1, 2013, Pages 187-192

  McDougall, Catherine J ^a   Gray, Hamish S ^a,b   Simpson, Philip M ^a,b   Whitehouse, Sarah L ^a,b   Crawford, Ross W ^a,b   Donnelly, William J ^a,b,c  

^a THE PRINCE CHARLES HOSPITAL   (Australia)

^b QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^c Holy Spirit Northside Private Hospital Australia   (Australia)

Author keywords

Anticoagulation; Complications; Total hip arthroplasty

Indexed keywords

ACETYLSALICYLIC ACID; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; WARFARIN;

ANTICOAGULANT THERAPY; ARTICLE; CARDIOVASCULAR RISK; CLINICAL PROTOCOL; DRUG INDICATION; FEMALE; HEMATOMA; HUMAN; INFECTION; INFECTIOUS ARTHRITIS; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE HEMORRHAGE; SUPERFICIAL INFECTION; THROMBOSIS; THROMBOSIS PREVENTION; TOTAL HIP PROSTHESIS; WOUND COMPLICATION;

ADULT; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; ARTHROPLASTY, REPLACEMENT, HIP; BLOOD LOSS, SURGICAL; CASE-CONTROL STUDIES; FEMALE; HEPARIN; HUMANS; MALE; MIDDLE AGED; POSTOPERATIVE HEMORRHAGE; PROSTHESIS-RELATED INFECTIONS; REOPERATION; SURGICAL WOUND INFECTION; THROMBOEMBOLISM; WARFARIN;

EID: 84870740116     PISSN: 08835403     EISSN: 15328406     Source Type: Journal    
DOI: 10.1016/j.arth.2012.06.001     Document Type: Article

References (22)

1. Nelson P. Deep infection following total hip arthroplasty. J Bone Joint Surg Am 1977, 59:1042.
2. Sachs R., Smith J., Kuney L., et al. Does anticoagulation do more harm than good? A comparison of patients treated without prophylaxis and patients treated with low-dose warfarin after total knee arthroplasty. J Arthroplasty 2003, 18(4):389.
3. Eikelboom J.W., Ginsberg J.S. Preventing thromboembolic complications in older orthopaedic surgery patients: interventions and outcomes. Drugs Aging 1999, 15(4):297. [Review].
4. Míka P., Behounek J., Skoták M., et al. Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and warfarin after total replacement of large joints-our experience. Acta Chir Ortho et Trauma Cech 2004, 7(4):237.
5. Juergens C.P., Semsarian C., Keech A.C., et al. Hemorrhagic complications of intravenous heparin use. Am J Cardiol 1997, 80(2):150.
6. Audebert H.J., Schenk B., Tietz V., et al. Initiation of oral anticoagulation after acute ischaemic stroke or transient ischaemic attack: timing and complications of overlapping heparin or conventional treatment. Cerebrovasc Dis 2008, 26(2):171.
7. Dunn A., Turpie A. Perioperative management of patients receiving oral anticoagulants-a systematic review. Arch Int Med 2003, 163(8):901.
8. Hutten B.A., Lensing A.W., Kraaijenhagen R.A., et al. Safety of treatment with oral anticoagulants in the elderly. A systematic review. Drugs Aging 1999, 14(4):303. Review].
9. Campbell N.R., Hull R.D., Brant R., et al. Aging and heparin-related bleeding. Arch Int Med 1996, 156(8):857.
10. Moeckel B., Huo M., Salvati E. Total hip arthroplasty in patients with diabetes mellitus. J Arthroplasty 1993, 8(3):279.
11. Krishnaswamy A., Lincoff A.M., Cannon C.P., et al. The use and limitations of unfractionated heparin [review]. Critical Pathways in Cardiology: A Journal of Evid Based Med 2010, 9(1):35.
12. Thakur N.A., Czerwein J., Butera J., et al. Review article-perioperative management of anticoagulation in orthopaedic surgery. J AAOS 2010, Vol 18(12):729.
13. Frank M. Oral anticoagulation in the elderly-practical aspects and risk-benefit trade off in atrial fibrillation (review). Praxis 2010, 99(7):429.
14. Garcia D., Regan S., Henault M., et al. Risk of thromboembolism with short-term interruption of warfarin therapy. Arch Intern Med 2008, 168(1):63.
15. Fuster V., Ryden L.E., Cannom D.S., et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines. Circulation 2006, 48:701.
16. White R., Henderson M. Risk factors for venous thromboembolism after total hip and knee replacement surgery. Review article. Curr Opin Pulm Med 2002, 8:365.
17. Milbrink J., Bergqvist D. The Incidence of symptomatic venous thromboembolic events in orthopaedic surgery when using routine thromboprophylaxis. Vasa 2008, 37(4):353.
18. White R., Romano P., Zhou H. Incidence and time course of thromboembolic outcomes following hip or knee arthroplasty. Arch Intern Med 1998, 158:1525.
19. A prospective comparison of warfarin to aspirin for thromboprophylaxis in total hip and total knee arthroplasty. J Arthroplasty 2011, Intermountain Joint Replacement Center Writing Committee, [Epub ahead of print].
20. Douketis J.D., Berger P., Dunn A., et al. The perioperative management of antithrombotic therapy. American College of Chest Physicians Guidelines (8th edition). Chest 2008, 133:299.
21. Cagatay O., Kursat G., Ahment A., et al. Efficacy of prophylactic placement of inferior vena cava filters in patients undergoing spinal surgery. Spine 2010, 35-10:1893.
22. Simpson P.M.S., Brew C., Donnelly W.J., et al. Complications of perioperative warfarin in total knee arthroplasty 2010.